{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:52:10Z","timestamp":1792011130715,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001725","name":"Royal Swedish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"SciLifeLab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"The Swedish Heart Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jacbts.2026.101736","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:36:57Z","timestamp":1791920217000},"page":"101736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Chemokine Profile Linked to Both Triglyceride-Rich Lipoproteins and Lipoprotein(a), But Not LDL, Is Associated With Cardiovascular Disease"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-6463","authenticated-orcid":false,"given":"Elias","family":"Bj\u00f6rnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Adiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Morze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentina","family":"Porsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Gummesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Wittenbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-8091","authenticated-orcid":false,"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2026.101736_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41569-024-01111-0","article-title":"Apolipoprotein B-containing lipoproteins in atherogenesis","volume":"22","author":"Boren","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101736_bib3","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101736_bib4","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101736_bib5","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.immuni.2025.09.012","article-title":"Inflammation in atherosclerosis: lessons and therapeutic implications","volume":"58","author":"Libby","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jacbts.2026.101736_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s44161-022-00049-1","article-title":"The why and how of adaptive immune responses in ischemic cardiovascular disease","volume":"1","author":"Mallat","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101736_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107255","article-title":"Inflammation and the pathogenesis of atherosclerosis","volume":"154","author":"Libby","year":"2024","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101736_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101736_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.metabol.2012.08.008","article-title":"Linkage between C-reactive protein and triglyceride-rich lipoprotein metabolism","volume":"62","author":"Thongtang","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.jacbts.2026.101736_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jacl.2019.07.003","article-title":"The association of plasma lipids with white blood cell counts: results from the Multi-Ethnic Study of Atherosclerosis","volume":"13","author":"Lai","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacbts.2026.101736_bib11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2024.07.034","article-title":"Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol","volume":"84","author":"Bjornson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamacardio.2023.5605","article-title":"Lipoprotein(a), C-Reactive protein, and cardiovascular risk in primary and secondary prevention populations","volume":"9","author":"Small","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib13","article-title":"Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data","volume":"342","author":"Collaboration","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacbts.2026.101736_bib14","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101736_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/ATVBAHA.123.319937","article-title":"Diacylglycerols and lysophosphatidic acid, enriched on lipoprotein(a), contribute to monocyte inflammation","volume":"44","author":"Dzobo","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2026.101736_bib16","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1194\/jlr.M060210","article-title":"Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)","volume":"56","author":"Scipione","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101736_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jacc.2023.10.039","article-title":"Lipoprotein(a) is markedly more atherogenic than LDL: an apolipoprotein B-Based genetic analysis","volume":"83","author":"Bjornson","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib18","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/eurheartj\/ehaf207","article-title":"ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease","volume":"46","author":"Morze","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101736_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2023.09.836","article-title":"Per-particle cardiovascular risk of lipoprotein(a) vs non-Lp(a) apolipoprotein B-containing lipoproteins","volume":"83","author":"Marston","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib20","doi-asserted-by":"crossref","first-page":"ehag718","DOI":"10.1093\/eurheartj\/ehag718","article-title":"Plasma proteomic profiling reveals distinct roles of apolipoprotein B-containing lipoproteins in atherosclerosis","volume":"31","author":"Morze","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101736_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacbts.2026.101736_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2026.109050","article-title":"Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular risk","volume":"284","author":"Chapman","year":"2026","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacbts.2026.101736_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomark Med"},{"key":"10.1016\/j.jacbts.2026.101736_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","article-title":"Oxidized phospholipids in cardiovascular disease","volume":"21","author":"Tsimikas","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2019.04.053","article-title":"Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: their annotation and biological meaning","volume":"1120","author":"Godzien","year":"2019","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jacbts.2026.101736_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/248492","article-title":"LPA promotes T cell recruitment through synthesis of CXCL13","volume":"2015","author":"Hui","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jacbts.2026.101736_bib27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00125-011-2444-6","article-title":"Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes","volume":"55","author":"Stahlman","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacbts.2026.101736_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jacbts.2026.101736_bib29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41556-024-01491-y","article-title":"Innate immune sensing of cell death in disease and therapeutics","volume":"26","author":"Man","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jacbts.2026.101736_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110241","article-title":"Damage-associated molecular patterns (DAMPs) in vascular diseases","volume":"301","author":"Antonello","year":"2025","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacbts.2026.101736_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41569-024-01023-z","article-title":"Targeting immune cell recruitment in atherosclerosis","volume":"21","author":"Doring","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2021.06.912","article-title":"Targeting the chemokine network in atherosclerosis","volume":"330","author":"Yan","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101736_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacbts.2026.101736_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79585-8","article-title":"Oxidized phospholipid and transcriptomic signatures of THC-related vaping associated lung injury","volume":"14","author":"Suber","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101736_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/ars.2009.2597","article-title":"Generation and biological activities of oxidized phospholipids","volume":"12","author":"Bochkov","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacbts.2026.101736_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib37","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacbts.2026.101736_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20080752","article-title":"Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-\/- mice","volume":"206","author":"Grabner","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacbts.2026.101736_bib39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0039-3400746","article-title":"Interruption of the CXCL13\/CXCR5 chemokine axis enhances plasma IgM levels and attenuates atherosclerosis development","volume":"120","author":"van der Vorst","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacbts.2026.101736_bib40","first-page":"2544","article-title":"Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies","volume":"117","author":"Porsch","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101736_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2012.06.071","article-title":"Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - potential role in plaque stabilization","volume":"224","author":"Smedbakken","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101736_bib42","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacbts.2026.101736_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s44161-023-00413-9","article-title":"Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis","volume":"3","author":"Doring","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101736_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2018.04.067","article-title":"Blood CSF1 and CXCL12 as causal mediators of coronary artery disease","volume":"72","author":"Sjaarda","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11883-026-01401-7","article-title":"Genetic variation in the chemokine network and atherosclerosis risk","volume":"28","author":"Zangas","year":"2026","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacbts.2026.101736_bib46","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/jamacardio.2022.3926","article-title":"Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review","volume":"8","author":"Stone","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2026.101736_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jacbts.2026.101736_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2026.120772","article-title":"Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study","volume":"417","author":"Wadstrom","year":"2026","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2026.101736_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2026.101736_bib51","article-title":"Triglycerides and T cells in cardiovascular risk: inflammatory transcriptomic profile in hypertriglyceridemia patients' T cells","volume":"10","author":"Reilly","year":"2025","journal-title":"JACC Basic Transl Sci"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26002603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26002603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:32:04Z","timestamp":1792009924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26002603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2452302X26002603"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101736","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Chemokine Profile Linked to Both Triglyceride-Rich Lipoproteins and Lipoprotein(a), But Not LDL, Is Associated With Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101736"}}